Nonprofit arts event in Houston pivots to virtual experience

the show must go on

The beloved festival, like so many others, is going virtual this year. Photo courtesy of Bayou City Arts Festival

As summer rolls on and Houston adapts to the new normal of the COVID-19 pandemic, myriad arts organizations are pivoting, morphing their in-person events into virtual experiences.

One such event is the 49-year-old, annual Bayou City Arts Festival, which has just announced that it has reimagined its outdoor event originally scheduled for October 10-11 this year. Due to the cancelation of the event because of coronavirus concerns, all 2020 festival tickets will be honored at Bayou City Art Festival events in 2021, according to organizers.

In place of an in-person festival in 2020, a Bayou City Art Virtual Experience will take place the week of October 5-11. The event will feature an art auction, virtual performances, art projects for kids with Bayou City Art Festival nonprofit partners, creative activities with Bayou City Art Festival sponsors and more, according to a press release.

"The decision to convert our Bayou City Art Festival Downtown to a virtual experience was difficult, but the health and safety of our community and our festival family is our top priority," says Kelly Batterson, executive director of the Art Colony Association.

Organizers have also announced that a fundraising campaign dubbed Save Our Art - One Passion. One Purpose. One Community, in partnership with the City of Houston to support the arts and the festival's local nonprofit partners.

Interested parties can donate by sending a text SaveOurArt to 243725, donating via our website and Facebook page, or by participating in the many upcoming fundraising events.

Festival fans can stay up to date via Facebook, Twitter, and Instagram.

------

This article originally appeared on CultureMap.

Some of the works will adorn the new Sunnyside Multi-Service and Health Center. Rendering courtesy of the City of Houston

City of Houston calls local and Texas artists for $3 million public project

call for artists

Houstonians love their public art, and the City of Houston is banking on that love and civic pride with a hefty new call to local artists. The Mayor's Office of Cultural Affairs (MOCA) has announced new opportunities for artists and artist groups to have their artwork pegged for the City's Art Collection.

MOCA's call boasts more than $3 million in artist opportunities, in effort to help those affected by the economic downturn of COVID-19. The new series of projects will adorn Houston's airports and the new Sunnyside Multi-Service and Health Center. Some 100 opportunities open to Houston and Texas artists in the calls for qualifications, according to a press release.

These new works promise to have a large audience; nearly 60 million passengers passed through the Houston Airport System in 2019. The Houston Arts Alliance is managing the selection process. Selected artists must sign a contract with Houston Arts Alliance for the commission, according to MOCA. Funding for the project comes courtesy of the City of Houston Civic Art Program.

"This is a difficult time for all people, including artists – many of which are either self-employed or small business owners," Houston Airports curator of public art, Alton DuLaney, said in a statement. "It's unfortunate that many galleries are closed, and many artists are out of work. We hope this will be a lifeline for some of them. We are honored to be in a position to lift-up our Texas artists in this way while enriching Houston Airports' public art collection."

The pre-application workshops and submission deadlines for each opportunity are as follows:

Sunnyside Multi-Service and Health Center
RFQ submission deadline: Monday, July 27
Artist Info Session: Thursday, July 16

Houston Airports Portable Works
RF deadline: Monday, August 3
Artist Info Session #1: Saturday, July 11
Artist Info Session #2: Thursday, July 16

Houston Airports New Commissions
RFQ deadline: Monday, August 10
Artist Info Session #1: Saturday, July 11
Artist Info Session #2: Thursday, July 16

Ticket-holders can watch a taped performance of the Alley Theatre's 1984. Photo by Lynn Lane

Local arts organizations innovate new ways to get to patrons in Houston and beyond

tech culture

With the city of Houston — and much of the rest of the state — issuing stay-at-home mandates, cultural events and institutions have closed their doors. But, thanks to a little innovation, many are now providing online options.

Arts groups all across Texas are using technology to stream concerts, opera, dance, and even museum tours for free during the coronavirus quarantine, and we're adding more here as they come in.

The Alley Theatre
Patrons can watch a taped performance of the recently canceled 1984. Current ticket holders will be sent a password protected link, and those who would like to still watch are welcome to purchase tickets to gain access to the link.

Houston Symphony
You can listen to Houston Public Media broadcasts and national broadcasts anytime on the symphony's website, or tune in to I Heart Radio to hear selected albums.

ROCO
The Houston-based music ensemble has its entire archive of audio and video recordings available online, including a number of its more than 100 world-premiere commissions (and several of which were also included in the Grammy-winning debut album Visions Take Flight).

Ars Lyrica Houston
The early music ensemble has created two new series: Musical Moments and Concerts & Conversations. All of their content will be aired on their social media platforms as well as newsletters and YouTube. They will be posting new content on Mondays and Fridays at 10 am.

Fusebox Festival
The Austin festival originally scheduled for April 15-19 will now go digital; keep an eye on the Facebook page for updates about how to watch and listen.

Black Fret
Celebrate the Austin music scene in a safe and responsible way through a livestream of Austin Love & Lightstream, a local response to the cancelation of SXSW. Closed to the public and taking place on a sterilized outdoor sound stage at Scholz Garten, Austin bands and personalities will be livestreamed six hours a day starting at 4 pm each day, beginning March 17. Viewers can access the Facebook Live stream from the Black Fret website.

Dallas Theater Center
A video was taken of the final dress rehearsal for American Mariachi, a new work by José Cruz Gonzalez about a young woman who forms the first all-female mariachi band in the 1970s, despite disapproving relatives and going against social norms. Patrons are encouraged to pay-what-you-can — starting at $15 — to receive a link and a password to access the recording within 24 hours. Purchasers will have up to two weeks to watch the video. Dallas Theater Center is allowed to sell the video up to the original close date of April 5, 2020; after that, it will be deleted. The number of videos for sale is the same as the number of seats available throughout the run, so patrons are encouraged to buy their "tickets" soon.

Avant Chamber Ballet
Watch the 360-degree world premiere video of 19th Amendment recorded on February 15, 2020, at Moody Performance Hall, spotlighting choreographer Katie Puder and composer Quinn Mason.

American Baroque Opera Company
Enjoy the full-length production of La Serva Padrona by Giovanni Battista Pergolesi.

Dallas Museum of Art
Browse more than 25,000 works of art from all cultures and time periods.

Thin Line Fest and Dallas VideoFest
The Denton-based multidisciplinary festival will be streaming its selection of documentaries online March 25-29, while Dallas VideoFest will host its Alternative Fiction festival April 3-5. Featuring a curated collection of over 50 documentary features and shorts, Thin Line Fest's film division will stream all screenings and Q&A sessions online. Attendees will be able to login at www.thinline.us and then choose which "theater" to stream live. The fest will still hold its Photography & Film Award Ceremony, which will be live-streamed on March 29.

------

This article originally ran on CultureMap. Click here for latest update to the story.

If you have a virtual concert or artwork that can be enjoyed from home during this time, email lindseyw@culturemap.com and we'll add you to the ever-growing list.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Rice team keeps CO2-to-fuel devices running 50 times longer in new study

Bubbling Up

In a new study published in the journal Science, a team of Rice University researchers shared findings on how acid bubbles can improve the stability of electrochemical devices that convert carbon dioxide into useful fuels and chemicals.

The team led by Rice associate professor Hoatian Wang addressed an issue in the performance and stability of CO2 reduction systems. The gas flow channels in the systems often clog due to salt buildup, reducing efficiency and causing the devices to fail prematurely after about 80 hours of operation.

“Salt precipitation blocks CO2 transport and floods the gas diffusion electrode, which leads to performance failure,” Wang said in a news release. “This typically happens within a few hundred hours, which is far from commercial viability.”

By using an acid-humidified CO2 technique, the team was able to extend the operational life of a CO2 reduction system more than 50-fold, demonstrating more than 4,500 hours of stable operation in a scaled-up reactor.

The Rice team made a simple swap with a significant impact. Instead of using water to humidify the CO2 gas input into the reactor, the team bubbled the gas through an acid solution such as hydrochloric, formic or acetic acid. This process made more soluble salt formations that did not crystallize or block the channels.

The process has major implications for an emerging green technology known as electrochemical CO2 reduction, or CO2RR, that transforms climate-warming CO2 into products like carbon monoxide, ethylene, or alcohols. The products can be further refined into fuels or feedstocks.

“Using the traditional method of water-humidified CO2 could lead to salt formation in the cathode gas flow channels,” Shaoyun Hao, postdoctoral research associate in chemical and biomolecular engineering at Rice and co-first author, explained in the news release. “We hypothesized — and confirmed — that acid vapor could dissolve the salt and convert the low solubility KHCO3 into salt with higher solubility, thus shifting the solubility balance just enough to avoid clogging without affecting catalyst performance.”

The Rice team believes the work can lead to more scalable CO2 electrolyzers, which is vital if the technology is to be deployed at industrial scales as part of carbon capture and utilization strategies. Since the approach itself is relatively simple, it could lead to a more cost-effective and efficient solution. It also worked well with multiple catalyst types, including zinc oxide, copper oxide and bismuth oxide, which are allo used to target different CO2RR products.

“Our method addresses a long-standing obstacle with a low-cost, easily implementable solution,” Ahmad Elgazzar, co-first author and graduate student in chemical and biomolecular engineering at Rice, added in the release. “It’s a step toward making carbon utilization technologies more commercially viable and more sustainable.”

A team led by Wang and in collaboration with researchers from the University of Houston also recently shared findings on salt precipitation buildup and CO2RR in a recent edition of the journal Nature Energy.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings